Analystreport

X4 Pharmaceuticals (XFOR) is now covered by Guggenheim. They set a "buy" rating and a $12.00 price target on the stock.

X4 Pharmaceuticals, Inc.  (XFOR) 
Last x4 pharmaceuticals, inc. earnings: 3/12 07:30 am Check Earnings Report